-
Views
-
Cite
Cite
Francesco Locatelli, Adrian Covic, Kai-Uwe Eckardt, Andrzej Wiecek, Raymond Vanholder, on behalf of the ERA-EDTA ERBP Advisory Board, Anaemia management in patients with chronic kidney disease: a position statement by the Anaemia Working Group of European Renal Best Practice (ERBP), Nephrology Dialysis Transplantation, Volume 24, Issue 2, February 2009, Pages 348–354, https://doi.org/10.1093/ndt/gfn653
- Share Icon Share
Extract
Introduction
Over the last few years, much has been done to develop guidelines on the basis of the strongest possible evidence because this allows an accurate description of the quality and/or degree of uncertainty of the recommendations and provides physicians with a valuable tool for judicious decisions. However, creating and updating evidence-based guidelines is extremely costly, and so the nephrological community has been trying to build up a single set of international guidelines under the aegis of Kidney Disease Improving Global Outcomes (KDIGO) [ 1 ]. As part of this unifying effort, the working group responsible for the 2006 update of the National Kidney Foundation–Kidney Disease Outcome Quality Initiative (NKF-KDOQI) guidelines on anaemia management in patients with chronic kidney disease (CKD) [ 2 ], and the 2007 update on haemoglobin (Hb) targets [ 3 ], included members from Europe, Middle East, Mexico and Canada. However, this international effort may not be correctly perceived by European nephrologists, who sometimes feel that differences in practice patterns make it difficult to apply guidelines developed outside Europe; on the other hand, the latest update of the European Best Practice Guidelines (EBPG) [ 4 ] may appear outdated in some respects.
Comments